| Metric | შპს Europharma Georgia ევროფარმა ჯორჯია | შპს საფ ფარმა | შპს არტ ფარმა |
|---|---|---|---|
| Growth | |||
| Revenue | ₾6.4m₾5.4m | ₾6.4m₾6.5m | ₾6.2m₾5.7m |
| Revenue growth | 19.8% | -1.3% | 10.0% |
| Profitability | |||
| EBITDA | ₾651k₾577k | ₾1.4m₾1.2m | ₾2.0m₾2.1m |
| EBITDA margin | 10.2%10.8% | 22.5%18.4% | 31.4%36.9% |
| Net profit | ₾643k₾577k | ₾1.5m₾1.1m | |
| ₾2.0m₾2.1m |
| Net margin | 10.0%10.8% | 23.0%17.7% | 31.4%36.8% |
| Balance sheet | |||
| Total assets | ₾5.1m₾4.9m | ₾5.3m₾5.4m | ₾13.7m₾9.8m |
| Total equity | ₾3.1m₾2.2m | ₾2.7m₾1.2m | ₾11.4m₾9.4m |
| ROE | 20.6%26.4% | 54.6%93.9% | 17.2%22.2% |